Omega-3 supplement to boost DHA and EPA levels in the blood

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 12-week, single-arm study in the United States where participants will take two Omega Active capsules daily and have blood tests at baseline and week 12 to measure DHA and EPA. Participants complete questionnaires at baseline, week 4, week 8, and week 12 about cognitive performance, digestive symptoms, and overall health. There is no randomization or placebo control; all participants receive the active supplement for the full duration. Blood biomarker testing is performed at a Quest Diagnostics center to quantify changes in fatty acid levels. The study aims to understand how this omega-3 supplement affects blood DHA and EPA in otherwise healthy adults.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Be male or female.
* Be aged 18-65.
* Anyone in good general health.
* Willing to avoid taking other supplements, prescription medications, or herbal remedies that target DHA or EPA levels in the body, for the duration of the study.
* Must not have taken fish oil or plant-based omega oil supplements in the past eight weeks.
* Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
* Resides in the United States.

Exclusion Criteria:

* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
* Anyone on anticoagulants or antiplatelet therapy.
* Anyone with a bleeding disorder.
* Anyone with any allergies or sensitivities to any of the study product ingredients.
* Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
* Anyone unwilling to follow the study protocol.
* Anyone who does not consume any specific dietary ingredients for any reason.
* Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.

Where it's running

• Citruslabs
  Las Vegas, Nevada, United States Recruiting

Study contacts

• Study coordinator: Patrick Renner
• Phone: 4242450284

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digital Health Education to Improve Heart Health Across Different Socioeconomic Groups (e-DUCASS Advance)

  This study tests a 24-month digital health education program to see if it can improve cardiovascular health among people in Córdoba, Spain from varied socioeconomic backgrounds, by delivering weekly online content to families.

  Recruiting Maimónides Biomedical Research Institute of Córdoba · Córdoba · NCT07835386

• Peanuts and stress: does eating peanuts affect heart health markers in people under high stress

  This study tests whether adding roasted peanuts to the diet can improve immune and cardiovascular risk markers in adults who report high chronic stress.

  Recruiting USDA, Western Human Nutrition Research Center · Davis, California · NCT07735221

• Beetroot Extract and Exercise for Health in Adults Aged 75+

  This study tests whether beetroot extract, alone and with a multicomponent exercise program, can improve blood pressure, functional performance, and cognitive function in adults 75 and older.

  Recruiting Fundacion Miguel Servet · Pamplona, Navarre · NCT07666685

• Dyadic Multidimensional Sleep Health Promotion for Couples

  A couples-focused program tests whether a multidimensional sleep health approach can improve sleep quality and blood pressure in both partners.

  Recruiting Columbia University · New York, New York · NCT07603245

• Self-affirmation and heart responses during grief

  This trial will test whether a brief self-affirmation exercise helps adults grieving a recent loss have calmer heart and blood pressure responses during and after recalling their loss.

  Recruiting University of South Florida · Tampa, Florida · NCT07356635

• A new insulin-sensitizing pill for adults with type 1 diabetes using closed‑loop insulin delivery

  This 12-week test will see if the oral drug CIR-0602K helps adults with type 1 diabetes who use closed-loop insulin systems spend more time in their target glucose range and use less insulin.

  Recruiting Phase 2 University of Virginia · Charlottesville, Virginia · NCT07186660

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.